VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $380,777 | -10.6% | 14,150 | 0.0% | 0.02% | -11.1% |
| Q2 2023 | $426,057 | -27.4% | 14,150 | -22.0% | 0.02% | -30.8% |
| Q1 2023 | $587,153 | +12.9% | 18,150 | 0.0% | 0.03% | +8.3% |
| Q4 2022 | $520,179 | +18.8% | 18,150 | 0.0% | 0.02% | +4.3% |
| Q3 2022 | $438,000 | -12.7% | 18,150 | -1.1% | 0.02% | -4.2% |
| Q2 2022 | $502,000 | -28.7% | 18,350 | 0.0% | 0.02% | -20.0% |
| Q1 2022 | $704,000 | +19.7% | 18,350 | 0.0% | 0.03% | +30.4% |
| Q4 2021 | $588,000 | +8.7% | 18,350 | 0.0% | 0.02% | +4.5% |
| Q3 2021 | $541,000 | -13.3% | 18,350 | 0.0% | 0.02% | -12.0% |
| Q2 2021 | $624,000 | -21.1% | 18,350 | -24.6% | 0.02% | -26.5% |
| Q1 2021 | $791,000 | -9.8% | 24,350 | 0.0% | 0.03% | -15.0% |
| Q4 2020 | $877,000 | -8.1% | 24,350 | 0.0% | 0.04% | -16.7% |
| Q3 2020 | $954,000 | +6.8% | 24,350 | 0.0% | 0.05% | 0.0% |
| Q2 2020 | $893,000 | +59.2% | 24,350 | 0.0% | 0.05% | +29.7% |
| Q1 2020 | $561,000 | -21.3% | 24,350 | 0.0% | 0.04% | +8.8% |
| Q4 2019 | $713,000 | +9.7% | 24,350 | 0.0% | 0.03% | +3.0% |
| Q3 2019 | $650,000 | +4.5% | 24,350 | 0.0% | 0.03% | +3.1% |
| Q2 2019 | $622,000 | +43.3% | 24,350 | +25.8% | 0.03% | +39.1% |
| Q1 2019 | $434,000 | +25.8% | 19,350 | +18.3% | 0.02% | +9.5% |
| Q4 2018 | $345,000 | +13.9% | 16,350 | 0.0% | 0.02% | +31.2% |
| Q3 2018 | $303,000 | -17.0% | 16,350 | 0.0% | 0.02% | -23.8% |
| Q2 2018 | $365,000 | +15.9% | 16,350 | +13.9% | 0.02% | +10.5% |
| Q1 2018 | $315,000 | -99.9% | 14,350 | 0.0% | 0.02% | -5.0% |
| Q4 2017 | $333,494,000 | +101266.0% | 14,350 | 0.0% | 0.02% | -4.8% |
| Q3 2017 | $329,000 | +3.8% | 14,350 | 0.0% | 0.02% | +5.0% |
| Q2 2017 | $317,000 | +12.4% | 14,350 | +16.2% | 0.02% | +11.1% |
| Q1 2017 | $282,000 | +9.3% | 12,350 | 0.0% | 0.02% | 0.0% |
| Q4 2016 | $258,000 | -20.9% | 12,350 | 0.0% | 0.02% | -21.7% |
| Q3 2016 | $326,000 | -4.7% | 12,350 | 0.0% | 0.02% | -8.0% |
| Q2 2016 | $342,000 | – | 12,350 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |